Logo image
Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes
Journal article   Open access   Peer reviewed

Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes

Junping Zhang, Ping Guo, Xiangping Yu, Dylan A. Frabutt, Anh K. Lam, Patrick L. Mulcrone, Matthew Chrzanowski, Jenni Firrman, Derek Pouchnik, Nianli Sang, …
Molecular therapy. Nucleic acids, v 29, pp 852-861
13 Sep 2022
url
https://doi.org/10.1016/j.omtn.2022.08.027View
Published, Version of Record (VoR)CC BY-NC-ND V4.0 Open

Abstract

DNA lesion/break MT: Oligonucleotides non-homologous end joining recombinant adeno-associated virus (rAAV) vectors snapback genomes subgenomic particles Therapies and Applications
Recombinant adeno-associated virus (rAAV) vectors have been developed for therapeutic treatment of genetic diseases. Current rAAV vectors administered to affected individuals often contain vector DNA-related contaminants. Here we present a thorough molecular analysis of the configuration of non-standard AAV genomes generated during rAAV production using single-molecule sequencing. In addition to the sub-vector genomic-size particles containing incomplete AAV genomes, our results showed that rAAV preparations were contaminated with multiple categories of subgenomic particles with a snapback genome (SBG) configuration or a vector genome with deletions. Through CRISPR and nuclease-based modeling in tissue culture cells, we identified that a potential mechanism leading to formation of non-canonical genome particles occurred through non-homologous end joining of fragmented vector genomes caused by genome lesions or DNA breaks present in the host cells. The results of this study advance our understanding of AAV vectors and provide new clues for improving vector efficiency and safety profiles for use in human gene therapy. [Display omitted] Zhang et al. revealed that vector DNA lesion and NHEJ are a potential mechanism leading to subgenomic AAV particle generation in the rAAV vector production process. This finding will provide an alternate pathway for discovering novel methodology to improve the safety and efficacy of AAV vectors.

Metrics

14 Record Views
16 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Medicine, Research & Experimental
Logo image